Type
- Cancellation by sponsor (513)
- ARTG (460)
- Australian public assessment report (AusPar) (69)
- Prescription medicine registration (44)
- Section 14, TGO91 consent (21)
- Prescription medicine decision summary (19)
- Designation or determination (9)
- Cancellation or suspension (7)
- Prescription medicine evaluation (1)
Date
- 2026 (4)
- 2025 (38)
- 2024 (86)
- 2023 (73)
- 2022 (59)
- 2021 (124)
- 2020 (107)
- 2019 (98)
- 2018 (95)
- 2017 (73)
- 2016 (12)
- 2015 (22)
- 2014 (19)
- 2013 (9)
- 2012 (8)
- 2011 (14)
- 2010 (27)
- 2009 (13)
- 2008 (5)
- 2007 (11)
- 2006 (8)
- 2005 (4)
- 2004 (8)
- 2003 (3)
- 2002 (10)
- 2001 (6)
- 2000 (20)
- 1999 (9)
- 1998 (12)
- 1997 (16)
- 1996 (8)
- 1995 (3)
- 1994 (31)
- 1993 (17)
- 1992 (5)
- 1991 (86)
Sponsor content
1143 result(s) found, displaying 481 to 490
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
-
Prescription medicine decision summaryAustralian prescription medicine decision summary
-
Cancellation by sponsorRequested by Pfizer Australia Pty Ltd
-
Cancellation by sponsorRequested by Pfizer Australia Pty Ltd
-
Cancellation by sponsorRequested by Pfizer Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MINULET tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LOETTE ethinylestradiol / levonorgestrel tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MONOFEME levonorgestrel and ethinylestradiol tablet blister pack.
-
Cancellation or suspensionRegulatory action due to The good had become an exempt good under Schedule 5, Item 8(f) of the Regulations. Exempt goods are not required to be included on the ARTG (paragraph 18(1) of the Act)., effective 22/06/2020